Status:
NOT_YET_RECRUITING
EC_ItaLynch: Mainstreaming the Diagnosis of Lynch Syndrome
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Lynch Syndrome
Endometrial Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
Lynch syndrome (LS) is the most common cause of hereditary endometrial cancer (EC) and is associated with an increased risk of colorectal (CRC), ovarian, gastric, small bowel and urinary tract cancer....
Eligibility Criteria
Inclusion
- Histologically confirmed diagnosis of stage I-IV EC with dMMR
- Only for part I presence of Lynch alert.
- Signed Informed consent to participate in the study.
- d. Patient must be ≥18 years
Exclusion
- Histologically confirmed diagnosis of stage I-IV EC with pMMR.
- Significant psychiatric or clinical impairment compromising consent to the study.
Key Trial Info
Start Date :
August 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT06501417
Start Date
August 1 2024
End Date
December 31 2028
Last Update
July 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Policlinico Universitario A. Gemelli IRCCS
Roma, Italy, 00168